PolyPid

PolyPid FCF/Net Income

The Free Cash Flow to Net Income Ratio of PolyPid (PYPD) as of Nov 5, 2026 is 82.21 %. In the previous year, Free Cash Flow to Net Income Ratio was 75.94 % — a change of 8.25% (higher).

FCF/Net Income

82.21 %

YoY

8.25%

Last updated:

Free Cash Flow to Net Income Ratio of PolyPid is 2025 82.21 % . Free Cash Flow to Net Income Ratio of PolyPid was 2024 75.94 % . It decreases by 8.25% higher compared to the previous year.

The PolyPid FCF/Net Income history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Net Income
Date
FCF/Net Income
Jan 1, 2018
-333.82 USD
Jan 1, 2019
264.11 USD
Jan 1, 2020
64.47 USD
Jan 1, 2021
86.90 USD
Jan 1, 2022
91.29 USD
Jan 1, 2023
73.04 USD
Jan 1, 2024
75.94 USD
Jan 1, 2025
82.21 USD
The PolyPid FCF/Net Income history
YEARFCF/Net IncomeYoY
82.21 %+8.25%
75.94 %+3.96%
73.04 %-19.99%
91.29 %+5.06%
86.90 %+34.80%
64.47 %-75.59%
264.11 %-179.12%
-333.82 %-1,381.28%
26.05 %-71.11%
90.17 %+10.86%
81.34 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PolyPid Stock analysis

What does PolyPid do? PolyPid Ltd is an innovative, emerging company in the field of biomedical technology based in Israel. The company was founded in 2008 and has since gained continuous recognition and growth. PolyPid's core business is the development and manufacturing of implantable polymer systems that contribute to wound healing. These polymer systems are specifically introduced into the affected area of the body and continuously release active substances to prevent infections and promote natural healing processes. PolyPid's business model is focused on effectively solving patients' problems. The company has developed a wide range of products and technologies that specifically target various medical applications. These include orthopedics, traumatology, urology, and gynecology. For orthopedics, PolyPid provides various products and technologies that can be used in knee and hip joint surgeries. These include antibiotic-releasing implants to prevent infections and resorbable bone fillers that allow for faster and more effective wound healing. In the field of traumatology, PolyPid manufactures polymer systems that are used in the treatment of bone fractures or other traumas. Here again, the polymer systems ensure continuous release of active substances to prevent infections and promote natural healing processes. PolyPid also offers innovative solutions for urology. Specifically, products are developed to combat urinary tract infections and promote faster wound healing after urological surgeries. For gynecology, PolyPid offers polymer systems that can be used particularly in the postoperative phase to prevent infections and achieve faster wound healing. PolyPid has earned an excellent reputation in the industry in recent years due to its consistent focus on innovation and quality. To continually improve their products, the company invests heavily in research and development and maintains close contact with medical institutions and professionals worldwide. PolyPid is an important partner in the field of biomedical technology and has already received numerous awards for its groundbreaking products and developments. Thanks to its focus on quality, reliability, and innovation, the company will continue to play a key role in the biomedical technology market. PolyPid is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PolyPid stock

Free Cash Flow to Net Income Ratio of PolyPid is 82.21 % in 2025.

Free Cash Flow to Net Income Ratio of PolyPid changed from 75.94 % to 82.21 %, representing a 8.25% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Net Income Ratio PolyPid since 2006 – with annual values, charts, and detailed analysis.

The FCF/Net Income ratio measures cash flow quality. Ratios consistently above 100% suggest high-quality earnings with strong cash backing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Net Income Ratio's PolyPid with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow to Net Income Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow to Net Income Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — PolyPid

All Key Metrics — PolyPid